Back to search results

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Canberra Hospital, Garran, Australian Capital Territory, Australia

    Contact: Study coordinator (Tze Jian Chin) · chin@act.gov.au · 5124 5288

  • Border Medical Oncology, Albury, New South Wales, Australia

  • Calvary Mater Newcastle, Newcastle, New South Wales, Australia

    Contact: Study coordinator (Kerrie Cornall) · paleo@calvarymater.org.au

  • Royal Brisbane and Women's Hospital, Herston, Queensland, Australia

    Contact: Study coordinator (Jacqui Keller) · jacqui.keller@health.qld.gov.au

  • Flinders Medical Centre, Bedford Park, South Australia, Australia

    Contact: Study coordinator (Aleksandra Kuruni, Dr) · Aleksandra.Kuruni@sa.gov.au

  • St Vincent's Hospital, Fitzroy, Victoria, Australia

    Contact: Study coordinator (Nadia Ranieri) · Nadia.RANIERI@svha.org.au

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Contact: Study coordinator (Shandelle Norman) · Shandelle.Norman@ctaust.org

  • Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

    Contact: Study coordinator (Aylin Yahya) · Aylin.Yahya@health.wa.gov.au

  • Auckland Hospital, Grafton, Auckland, New Zealand

    Contact: Study coordinator (Sophie Goodger) · SophieGo@adhb.govt.nz
Study leads

  • Fiona Day, Dr

    Study Chair

    Calvary Mater Newcastle

  • Jared Martin, Professor

    Study Chair

    Calvary Mater Newcastle

View source on ClinicalTrials.gov(opens in a new tab)